What one share of Olema Pharmaceuticals holds
Olema is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of next-generation targeted therapies for breast cancer and beyond. We are advancing our pipeline of novel therapies by leveraging our deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance.
Olema Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$2.13 |
|---|---|
| Cash and investments | $5.27 |
| Book value | $4.92 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | — | −$1.66 | — | — | — | −$4.09 |
| 2020 | — | −$3.42 | $0.01 | −$2.84 | — | — |
| 2021 | — | −$1.80 | $0.04 | −$1.32 | — | $7.15 |
| 2022 | — | −$2.62 | $0.01 | −$2.06 | — | $4.90 |
| 2023 | — | −$2.14 | — | — | — | $4.62 |
| 2024 | — | −$2.20 | $0.00 | −$1.78 | — | $5.50 |
| 2025 | — | −$1.87 | — | — | — | $5.88 |
Common questions about Olema Pharmaceuticals
How much does one share of Olema Pharmaceuticals earn?
Over the last 12 months, Olema Pharmaceuticals lost $2.13 for each share.
Does Olema Pharmaceuticals pay a dividend?
Olema Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Olema Pharmaceuticals’s book value per share?
Olema Pharmaceuticals’s book value is $4.92 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Olema Pharmaceuticals have?
Each share of Olema Pharmaceuticals has $5.27 of cash and investments, as of June 30, 2026.
Has Olema Pharmaceuticals bought back shares?
Olema Pharmaceuticals’s share count rose about 3255% from 2019 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.